Randomized phase III trial comparing surgery alone to UFT + PSK for stage II rectal cancer (JFMC38 trial)

[1] Torre LA(2015)Global cancer statistics, 2012 CA Cancer J Clin 65 87-108

[2] Bray F(2005)ESMO minimum clinical recommendations for diagnosis, treatment and follow-up of rectal cancer Ann Oncol 16 i20-i21

[3] Siegel RL(2015)Adjuvant chemotherapy for rectal cancer patients treated with preoperative (chemo)radiotherapy and total mesorectal excision: a Dutch Colorectal Cancer Group (DCCG) randomized phase III trial Ann Oncol 26 696-701

[4] Ferlay J(2005)Swedish rectal cancer trial: long lasting benefits from radiotherapy on survival and local recurrence rate J Clin Oncol 23 5644-5650

[5] Lortet-Tieulent J(2014)Treatment of stage II-III rectal cancer patients Curr Oncol Rep 16 362-649

[6] Jemal A(2015)Recent advances in multidisciplinary approach for rectal cancer Int J Clin Oncol 20 641-596

[7] Tveit K(2011)Final results of randomized trials by the National Surgical Adjuvant Study of Colorectal Cancer (NSAS-CC) Cancer Chemother Pharmacol 67 587-1126

[8] Breugom AJ(1994)Efficacy of immunochemotherapy as adjuvant treatment after curative resection of gastric cancer. Study Group of Immunochemotherapy with PSK for Gastric Cancer Lancet 343 1122-411

[9] van Gijn W(2006)Efficacy of adjuvant immunochemotherapy with polysaccharide K for patients with curatively resected colorectal cancer: a meta-analysis of centrally randomized controlled clinical trials Cancer Immunol Immunother 55 404-1068

[10] Muller EW(2003)Adjuvant therapy with protein-bound polysaccharide K and tegafur uracil in patients with stage II or III colorectal cancer: randomized, controlled trial Dis Colon Rectum 46 1060-164

[1] Torre LA(2015)Global cancer statistics, 2012 CA Cancer J Clin 65 87-108

[2] Bray F(2005)ESMO minimum clinical recommendations for diagnosis, treatment and follow-up of rectal cancer Ann Oncol 16 i20-i21

[3] Siegel RL(2015)Adjuvant chemotherapy for rectal cancer patients treated with preoperative (chemo)radiotherapy and total mesorectal excision: a Dutch Colorectal Cancer Group (DCCG) randomized phase III trial Ann Oncol 26 696-701

[4] Ferlay J(2005)Swedish rectal cancer trial: long lasting benefits from radiotherapy on survival and local recurrence rate J Clin Oncol 23 5644-5650

[5] Lortet-Tieulent J(2014)Treatment of stage II-III rectal cancer patients Curr Oncol Rep 16 362-649

[6] Jemal A(2015)Recent advances in multidisciplinary approach for rectal cancer Int J Clin Oncol 20 641-596

[7] Tveit K(2011)Final results of randomized trials by the National Surgical Adjuvant Study of Colorectal Cancer (NSAS-CC) Cancer Chemother Pharmacol 67 587-1126

[8] Breugom AJ(1994)Efficacy of immunochemotherapy as adjuvant treatment after curative resection of gastric cancer. Study Group of Immunochemotherapy with PSK for Gastric Cancer Lancet 343 1122-411

[9] van Gijn W(2006)Efficacy of adjuvant immunochemotherapy with polysaccharide K for patients with curatively resected colorectal cancer: a meta-analysis of centrally randomized controlled clinical trials Cancer Immunol Immunother 55 404-1068

[10] Muller EW(2003)Adjuvant therapy with protein-bound polysaccharide K and tegafur uracil in patients with stage II or III colorectal cancer: randomized, controlled trial Dis Colon Rectum 46 1060-164